Stay updated on ATHENA Clinical Trial: Rucaparib+Nivolumab in Ovarian Cancer

Sign up to get notified when there's something new on the ATHENA Clinical Trial: Rucaparib+Nivolumab in Ovarian Cancer page.
Latest website image capture
Clouds background image

Latest updates to the ATHENA Clinical Trial: Rucaparib+Nivolumab in Ovarian Cancer page

  1. Check
    yesterday
    No Change Detected
  2. Check
    8 days ago
    Change Detected
    Summary
    Fallopian tube cancer was added to the Conditions list, expanding the study’s scope. The page revision updated from v3.4.1 to v3.4.2.
    Difference
    0.0%
    Check dated 2026-02-16T15:33:08.000Z thumbnail image
  3. Check
    15 days ago
    Change Detected
    Summary
    Added Revision: v3.4.1. Removed the prior notices related to government funding lapse and Revision: v3.4.0.
    Difference
    0.1%
    Check dated 2026-02-09T12:31:35.000Z thumbnail image
  4. Check
    30 days ago
    Change Detected
    Summary
    Added a Show glossary option on the study page to improve access to defined terms. Metadata changes include addition of 'Last Update Submitted that Met QC Criteria' and 'Revision: v3.4.0', along with corresponding removals/renaming elsewhere.
    Difference
    0.1%
    Check dated 2026-01-26T09:42:55.000Z thumbnail image
  5. Check
    37 days ago
    Change Detected
    Summary
    Revision: v3.3.4 has been added and Revision: v3.3.3 has been removed. This is a versioning update with no substantive changes to the study record.
    Difference
    0.0%
    Check dated 2026-01-19T07:27:40.000Z thumbnail image
  6. Check
    65 days ago
    Change Detected
    Summary
    Added a consolidated Locations section listing study sites across the United States, Canada, Australia, and other countries. Removed several locale-specific location blocks in favor of the unified locations listing.
    Difference
    2%
    Check dated 2025-12-21T21:23:11.000Z thumbnail image
  7. Check
    87 days ago
    Change Detected
    Summary
    Revision tag updated from v3.3.1 to v3.3.2 on the Study Details page. No substantive content changes to the study information are evident.
    Difference
    0.0%
    Check dated 2025-11-30T05:39:54.000Z thumbnail image

Stay in the know with updates to ATHENA Clinical Trial: Rucaparib+Nivolumab in Ovarian Cancer

Enter your email address, and we'll notify you when there's something new on the ATHENA Clinical Trial: Rucaparib+Nivolumab in Ovarian Cancer page.